Quaker Chemical Accepts Resignation of Chief Financial Officer

Quaker Chemical Corp reported the resignation of its chief financial officer, according to an 8-K filed with the SEC on May 15, 2026.

The filing, submitted under Items 5.02, 5.07, 7.01 and 9.01, covers the departure of a principal officer, the submission of matters to a vote of security holders at the company's annual meeting, a Regulation FD disclosure, and related exhibits. Item 5.02 requires disclosure of the named individual's role, the nature of the separation, the effective date and any cited cause.

The resignation affects the company's senior financial leadership. Quaker Chemical, a publicly traded specialty chemical manufacturer with ticker KWR and CIK 0000081362, must now operate without its current CFO until a successor assumes the position.

The filing does not name the departing executive or provide an effective date beyond the reporting requirement triggered on the filing date of May 15, 2026.

The operational change shifts responsibility for financial reporting, internal controls and capital allocation to either an interim appointee or a newly recruited CFO. The company must file any subsequent 8-K announcing the election of a new principal financial officer, typically within four business days of the appointment under Item 5.02.

The departure also activates standard contractual obligations such as severance, equity vesting or non-compete provisions that the company will report in future proxy statements or Form 10-K exhibits.

Downstream, the transition requires the board's compensation committee to approve any new employment agreement and the audit committee to ensure continuity of financial oversight during the hand-off. Investors and analysts will receive updated guidance on the timing of the next quarterly report and any impact on the 2026 audit schedule.

The company must also maintain compliance with NYSE listing standards on timely disclosure of material executive changes.

This filing marks the latest executive departure reported by Quaker Chemical in its recent SEC record. The company routinely files Item 5.02 disclosures following board or officer changes and Item 5.07 updates after annual shareholder meetings that approve auditor ratification and director elections.

The current 8-K combines those routine items with a Regulation FD statement to ensure all material information reaches the market simultaneously.